After some time off following the split of Viaken Systems into two entities in June, Keith Elliston, founder and former CEO of Viaken, has resurfaced as CEO of Genstruct of Cambridge, Mass. Prior to founding Viaken in 1999, Elliston was the senior vice president of R&D and chief scientific officer at Gene Logic. He also founded the bioinformatics and genomics efforts of Bayer AG, where he was the worldwide head of bioinformatics and the section head for genomics, and spent 10 years in Merck’s computational molecular biology group. Elliston also holds a seat on Genstruct's board of directors.
Douglas Danne, formerly senior vice president and chief commercial officer of St. Louis-based Tripos, has left the company. CEO John McAlister said in a statement that the company is initiating a search for a replacement. Further details regarding Danne's departure were not provided.